Equities

Beijing Sun-Novo Pharmaceutical Research Co Ltd

688621:SHH

Beijing Sun-Novo Pharmaceutical Research Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)45.35
  • Today's Change-0.61 / -1.33%
  • Shares traded3.08m
  • 1 Year change-34.01%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
REVENUE AND GROSS PROFIT
Total revenue932677494
OPERATING EXPENSES
Cost of revenue total404301230
Selling, general and admin. expenses, total20412495
Depreciation/amortization29164.51
Unusual expense(income)--0.040.00
Other operating expenses, total(7.81)(16)(4.79)
Total operating expense738507371
Operating income194169123
Other, net(0.06)0.070.03
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes193169122
Provision for income taxes111013
Net income after taxes183159109
Minority interest1.86(2.23)(3.13)
Net income before extra. Items185156106
Total extraordinary items------
Net income185156106
Inc.avail. to common excl. extra. Items185156106
Inc.avail. to common incl. extra. Items185156106
EPS RECONCILIATION
Basic/primary weighted average shares11211298
Basic/primary eps excl. extra items1.651.401.08
Basic/primary eps incl. extra items1.651.401.08
Dilution adjustment------
Diluted weighted average shares11211298
Diluted eps excl. extra items1.651.401.08
Diluted eps incl. extra items1.651.401.08
COMMON STOCK DIVIDENDS
DPS - common stock primary issue0.170.43--
Gross dividend - common stock182121
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental129.703.56
SUPPLEMENTAL INCOME
Depreciation, supplemental443927
Total special items0.710.250.51
NORMALISED INCOME
Normalized income before taxes194169123
Effect of special items on income taxes0.040.020.06
Income tax excluding impact of special items111013
Normalized income after tax184159109
Normalized income avail. to common185157106
Basic normalized EPS1.661.401.08
Diluted normalized EPS1.661.401.08
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.